Medication info
Covalset Tablets 80/12.5 mg

Covalset Tablets 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Daewon Biotech Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201904738 · Approved 2019.07.16 · Insurance code 057600090

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Daewon Biotech Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for additional blood pressure control in patients with essential hypertension who do not achieve sufficient control with monotherapy.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication may cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this medication or sulfonamide drugs should not use it. It should not be administered to patients with severely impaired liver or kidney function, certain liver diseases, or very poor kidney function. Patients with a history of angioedema or those who have previously experienced angioedema after taking ACE inhibitors or angiotensin II receptor antagonists should also avoid this medication. Patients with electrolyte imbalances, fluid depletion, renal or hepatic dysfunction, acute angle-closure glaucoma, cerebrovascular disease, elderly patients, and those with heart failure should use this medication cautiously. In particular, this medication can cause or worsen electrolyte abnormalities such as hypokalemia, hyponatremia, hypercalcemia, and hyperuricemia, so regular blood tests are necessary. Dizziness or drowsiness may occur during the use of this medication, so caution is advised when driving or operating machinery. Potassium supplements or potassium-containing foods should not be taken without consulting a physician, and care should be taken, especially in cases of dehydration, excessive sweating, diarrhea, or vomiting, as blood pressure may drop excessively. Additionally, this medication may interact with other blood pressure medications, diuretics, lithium preparations, NSAIDs, etc., so it is essential to discuss any other medications being taken with a physician or pharmacist. The hydrochlorothiazide component may increase sensitivity to sunlight, raising the risk of skin cancer, so limiting sun exposure and taking protective measures is important. The safety and efficacy of this medication in pediatric patients have not been established, and it can be used in elderly patients without special dose adjustment but with caution. In case of overdose, symptoms such as hypotension, arrhythmia, and electrolyte disturbances may arise, necessitating immediate medical attention and appropriate treatment. Store this medication out of reach of children, keep it away from moisture, and store it in its original container.

Side effects

headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory infection, diarrhea, joint pain, abdominal pain, upper abdominal pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, shortness of breath, erectile dysfunction, gastritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myositis, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, renal function impairment, myalgia, anaphylaxis-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, vesicular dermatitis, renal failure, hypokalemia, increased blood lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, hyperglycemia, diabetes mellitus, urticaria, skin rash, photosensitivity reactions, necrotizing vasculitis, cutaneous lupus erythematosus, decreased appetite, nausea, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disorders, depression, paresthesia, visual impairment, leukopenia, bone marrow dysfunction, hemolytic anemia, acute respiratory distress syndrome, hypersensitivity reaction, pneumonia, pulmonary edema, vascular edema, serum sickness, erythema multiforme, fever, muscle cramps, acute angle-closure glaucoma, choroidal effusion, hypotension, tachycardia, nausea, drowsiness, hypovolemia, arrhythmia, muscle spasms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is advisable to maintain a storage temperature below 30 degrees Celsius. This will help preserve the medication's effectiveness for a longer duration.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.